Khas

<h3> Absolute Contraindications of Khas (Vetiver/Ushira) </h3> <h4> Pregnancy and Breastfeeding (avoid use)</h4> <ul> <li> 🤰</li> <li> Recommendation: Pregnant or breastfeeding people should avoid internal use of vetiver essential oil or high-dose extracts; topical or aromatic use should be discussed with a qualified practitioner. </li> <li> Reasoning: Some essential-oil constituents (including sesquiterpenoids present in various oils) can be anti-angiogenic or fetotoxic in animal models and essential oil components cross placenta and milk; until safety is proven in humans, avoidance is advised. </li> <li> Scientific_Study_Title: Maternal Reproductive Toxicity of Some Essential Oils and Their Constituents. </li> <li> Scientific_Study_Authors: Noura S. Dosoky, William N. Setzer.</li> <li> Scientific_Study_Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7956842/</li> <li> Scientific_Study_Excerpt: <p>This comprehensive review examines experimental and animal evidence that certain essential-oil constituents can cause maternal toxicity, embryo-fetotoxicity, teratogenicity or interfere with angiogenesis - processes critical for normal fetal development. The authors summarize data showing that low-molecular lipophilic oil constituents readily cross the placenta and that some classes (e.g., β-eudesmol and other sesquiterpenoids present in various oils) possess anti-angiogenic or embryo-toxic actions in animal experiments. The review recommends avoiding or restricting use of essential oils with potentially hazardous constituents during pregnancy and lactation due to the uncertainty and ethical limits on human testing.</p> <p>Although the paper does not single out vetiver as a commonly reported human teratogen, it lists β-eudesmol (a component that can be present in vetiver chemotypes) among constituents with theoretical reproductive risk, supporting a precautionary prohibition of high-dose or internal vetiver oil use in pregnancy and breastfeeding.</p> </li> </ul> <h4>Consumption of Roots/Oil from Contaminated Sources (heavy-metal/pesticide exposure risk)</h4> <ul> <li> ⚠️</li> <li> Recommendation: Do not ingest or use root powders or extracts if the plant source is unknown, grown near industrial/contaminated land, or not batch-tested - only use products certified free of heavy metals and agrochemical residues. </li> <li> Reasoning: Vetiver is widely used for phytoremediation and is known to concentrate heavy metals and environmental toxins in its root system; using roots from contaminated soils can transfer metals and toxins into preparations, creating safety hazards.</li> <li> Scientific_Study_Title: Vetiver grass, Vetiveria zizanioides: a choice plant for phytoremediation of heavy metals and organic wastes.</li> <li> Scientific_Study_Authors: Luu Thai Danh, Paul Truong, Raffaella Mammucari, Tam Tran, Neil Foster.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19810597/</li> <li> Scientific_Study_Excerpt: <p>The review surveys greenhouse and field studies showing vetiver’s exceptional tolerance to harsh soils and ability to accumulate a wide range of heavy metals (As, Cd, Cr, Cu, Hg, Ni, Pb, Se, Zn) and organic pollutants. Root tissues especially retain higher metal concentrations relative to shoots. The authors highlight vetiver’s use in phytostabilization and phytoextraction precisely because of its root accumulation profile, noting root lead and zinc accumulation percentages recorded in multiple studies.</p> <p>Practical implication: roots harvested from contaminated sites can carry concentrated heavy metals - a direct safety concern when roots are used as food, powders, or extracts. The paper supports caution and source-certification for any vetiver product intended for ingestion or broad topical use.</p> </li> </ul> <h4>Known or Suspected Fragrance/Skin Sensitivity (contact allergy risk)</h4> <ul> <li> 🧴</li> <li> Recommendation: If you have a history of fragrance or essential-oil allergies, atopic dermatitis, or sensitive skin, avoid undiluted vetiver oil and perform patch testing before topical or aromatic use; discontinue if rash or respiratory irritation occurs. </li> <li> Reasoning: Essential oils can cause allergic contact dermatitis and vetiver (vetiveria extract/oil) has been identified in fragrance safety literature as a possible contact allergen; aromatherapy case reports show dermatitis is the commonest essential-oil adverse effect.</li> <li> Scientific_Study_Title: Adverse effects of aromatherapy: a systematic review of case reports and case series. </li> <li> Scientific_Study_Authors: T. L. Posadzki, E. Alotaibi, E. Ernst. </li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22936057/</li> <li> Scientific_Study_Excerpt: <p>This systematic review collated 42 reports (case reports/series) of adverse events attributed to aromatherapy; 71 patients were included overall. The most frequently documented adverse reaction was dermatitis (skin reactions), with occasional reports of more severe effects. The authors concluded that aromatherapy can cause harms including contact dermatitis, respiratory and systemic effects, and that the true frequency is unknown because adverse events are under-reported. The review underlines that essential oils are not inherently risk-free and that vulnerable individuals can experience significant reactions.</p> <p>Although the review addresses aromatherapy broadly, separate fragrance/allergen monographs identify vetiver extract/oil as a possible fragrance contact allergen; together these sources justify advising avoidance in people with known fragrance sensitivity.</p> </li> </ul> <h3> Relative Contraindications of Khas (Vetiver) </h3> <h4>Concurrent use with Anticoagulant or Antiplatelet Therapy</h4> <ul> <li> 🩸</li> <li> Recommendation: Consult your prescriber before using vetiver extracts or root oil if you are taking warfarin, DOACs, aspirin, clopidogrel or other blood-thinning drugs; monitor bleeding parameters where relevant. </li> <li> Reasoning: Certain vetiver constituents (e.g., nootkatone and related sesquiterpenoids found in vetiver oil and other plants) have shown effects on platelet aggregation and thrombogenicity in preclinical models, implying potential additive effects with anticoagulants or antiplatelet agents.</li> <li> Scientific_Study_Title: Thrombosis and systemic and cardiac oxidative stress and DNA damage induced by pulmonary exposure to diesel exhaust particles and the effect of nootkatone thereon.</li> <li> Scientific_Study_Authors: Abderrahim Nemmar, Suhail Al-Salam, Sumaya Beegam, Priya Yuvaraju, Badreldin H. Ali.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29351455/</li> <li> Scientific_Study_Excerpt: <p>In mice and in vitro whole-blood assays, nootkatone (a sesquiterpenoid present in several plant oils including components found in vetiver chemistries) inhibited particle-induced thrombogenic responses and reduced platelet aggregation. The compound also attenuated increases in fibrinogen and related pro-thrombotic markers. While this is preclinical, it demonstrates that sesquiterpenoid constituents can alter haemostatic pathways and therefore could interact with anticoagulant medications or bleeding disorders.</p> <p>Clinical translation is not established, but the study supports a precautionary approach: discuss vetiver use with clinicians when on blood-thinning therapy.</p> </li> </ul> <h4>Use in Severe Asthma or Reactive Airway Disease (caution with inhalation)</h4> <ul> <li> 🌬️</li> <li> Recommendation: People with severe asthma, COPD or a history of essential-oil induced bronchospasm should avoid direct inhalation of concentrated vetiver oil and only use diluted, limited exposures under supervision. </li> <li> Reasoning: Aromatherapy reports include episodes of respiratory irritation and asthma exacerbation; although vetiver volatiles at low doses may influence attention or mood, concentrated inhalation or sprays can provoke airway symptoms in susceptible individuals. </li> <li> Scientific_Study_Title: Adverse effects of aromatherapy: a systematic review of case reports and case series. </li> <li> Scientific_Study_Authors: T. L. Posadzki, E. Alotaibi, E. Ernst.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22936057/</li> <li> Scientific_Study_Excerpt: <p>The systematic review of aromatherapy adverse events documents respiratory reactions among reported harms, including cases where inhalation or topical exposure precipitated bronchospasm or airway symptoms in susceptible people. The authors emphasize that essential oils can cause respiratory and allergic reactions, and that vulnerable populations (children, asthmatics) are more likely to experience clinically significant reactions. This supports a relative contraindication and the need for caution with inhaled vetiver preparations in reactive airway disease.</p> </li> </ul> <h4>Concomitant Use with Antidiabetic Medication (monitoring suggested)</h4> <ul> <li> 🩺</li> <li> Recommendation: If you are taking insulin or oral hypoglycemics, mention vetiver use to your clinician - monitor blood glucose closely if starting vetiver extracts, and adjust medications only under medical supervision. </li> <li> Reasoning: Preclinical and review literature indicates vetiver extracts can show antihyperglycemic effects in animal models; while human evidence is limited, theoretical additive glucose-lowering could raise hypoglycaemia risk when combined with antidiabetic drugs.</li> <li> Scientific_Study_Title: Pharmacological and Therapeutic Potential of Chrysopogon zizanioides (Vetiver): A Comprehensive Review of Its Medicinal Applications and Future Prospects.</li> <li> Scientific_Study_Authors: (Review authors as listed on PubMed entry - see linked review).</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/41008619/</li> <li> Scientific_Study_Excerpt: <p>Recent comprehensive reviews summarize preclinical findings where vetiver extracts produced antihyperglycemic effects in animal models, likely via antioxidant and metabolic modulation. The reviews emphasize promising laboratory data but note limited human clinical evidence. Because these preclinical findings show biological plausibility for glucose lowering, concurrent use with antidiabetic medication warrants monitoring to avoid unexpected hypoglycemia until robust human data are available.</p> </li> </ul>